CLINICAL CHARACTERISTICS: KMT2B-related disorders include KMT2B-related dystonia (DYT-KMT2B), reported in 93% families, and KMT2B-related neurodevelopmental disorder (NDD) that is non-dystonic, reported in 7% of families.
CLINICAL CHARACTERISTICS: KMT2B-related disorders include KMT2B-related dystonia (DYT-KMT2B), reported in 93% families, and KMT2B-related neurodevelopmental disorder (NDD) that is non-dystonic, reported in 7% of families.